Epidemiology of Congenital Bleeding Disorders: a Nationwide Population-based Korean Study
- 저자
- 회수
; 한유진
; 김영진
; 김민진
; 변자민
; Youk Taemi
; 이재희
; 박태성
; 유종하
- 키워드 (영문)
- congenital bleeding disorder; epidemiology; korea; nationwide; von willebrand disease; population based; population; pediatrics; medicine; health insurance; incidence (epidemiology)
- 발행연도
- 2020-09
- 발행기관
- 대한의학회
- 유형
- Article
- 초록
- Background: Except for data in the Korea Hemophilia Foundation Registry, little is known of the epidemiology of congenital bleeding disorders in Korea.
Methods: Data were obtained from the Korean Health Insurance Review and Assessment Service (HIRA) database.
Results: From 2010 to 2015, there were 2,029 patients with congenital bleeding disorders in the Korean HIRA database: 38% (n = 775) of these patients had hemophilia A (HA), 25% (n = 517) had von Willebrand disease (vWD), 7% (n = 132) had hemophilia B (HB), and 25% (n = 513) had less common factor deficiencies. The estimated age-standardized incidence rate (ASR) of HA and HB was 1.78–3.15/100,000 and 0.31–0.51/100,000, respectively. That of vWD was 1.38–1.95/100,000. The estimated ASR of HA showed increase over time though the number of new patients did not increase. Most patients with congenital bleeding disorders were younger than 19 years old (47.8%), and most were registered in Gyeonggi (22.1%) and Seoul (19.2%).
Conclusion: This is the first nationwide population-based study of congenital bleeding disorders in Korea. This study provides data that will enable more accurate estimations of patients with vWD. This information will help advance the comprehensive care of congenital bleeding disorders. We need to continue to obtain more detailed information on patients to improve the management of these diseases.
- 저널명
- Journal of Korean Medical Science
- 저널정보
- (2020-09). Journal of Korean Medical Science, Vol.35(39), 1–7
- ISSN
- 1011-8934
- EISSN
- 1598-6357
- DOI
- 10.3346/jkms.2020.35.e350
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.